Valuation: Mega Lifesciences

Market Cap 32.48B 971M 852M 789M 726M 1.37B 92.96B 1.4B 9.4B 3.69B 45.65B 3.65B 3.57B 158B P/E 2026 *
14x
P/E 2027 * 13.2x
Enterprise Value 27.87B 833M 731M 677M 623M 1.18B 79.76B 1.2B 8.07B 3.16B 39.17B 3.13B 3.06B 135B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.78x
Free-Float
38.61%
Yield 2026 *
4.69%
Yield 2027 * 5.04%
1 day+0.68%
1 week-1.32%
Current month+1.36%
1 month+9.56%
3 months+8.76%
6 months+3.47%
Current year+11.19%
1 week 36.5
Extreme 36.5
38
1 month 34
Extreme 34
38
Current year 31.5
Extreme 31.5
40
1 year 26.5
Extreme 26.5
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 61 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap.
28/04/25Buy

Chief Executive Officer

100,000 0.0115%
27/04/25Buy

Chief Executive Officer

150,000 0.0172%
27/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%-1.32%+40.57%-1.97% 970M
-0.28%-1.25%+48.26%+172.62% 1,060B
+0.32%-0.64%+64.31%+62.25% 619B
-0.47%-3.16%+28.82%+84.68% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.28%-2.08%+20.80%+57.60% 196B
+0.94%+1.10%+16.90%+70.81% 161B
Average -0.23%-3.13%+26.86%+50.09% 357.49B
Weighted average by Cap. -0.33%-3.09%+35.55%+83.94%

Financials

2026 *2027 *
Net sales 14.88B 445M 390M 361M 333M 629M 42.58B 641M 4.31B 1.69B 20.91B 1.67B 1.63B 72.22B 15.61B 467M 410M 379M 349M 660M 44.69B 673M 4.52B 1.77B 21.94B 1.75B 1.71B 75.79B
Net income 2.32B 69.38M 60.85M 56.36M 51.86M 98.09M 6.64B 100M 672M 263M 3.26B 261M 255M 11.26B 2.46B 73.56M 64.52M 59.76M 54.99M 104M 7.04B 106M 712M 279M 3.46B 276M 270M 11.94B
Net Debt -4.61B -138M -121M -112M -103M -195M -13.2B -199M -1.34B -524M -6.48B -518M -507M -22.39B -4.76B -142M -125M -116M -106M -201M -13.61B -205M -1.38B -540M -6.69B -534M -522M -23.09B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
12/07/26 THB 37.25 +0.68% 700,210
10/07/26 THB 37.00 -1.33% 702,563
09/07/26 THB 37.50 +1.35% 457,501
08/07/26 THB 37.00 -1.99% 1,334,709
07/07/26 THB 37.75 -0.66% 541,492
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.25THB
Average target price
41.14THB
Spread / Average Target
+10.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock